PDI, lnc. (PDII):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:PDI, lnc. (PDII) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME63409D
◆発行会社(調査会社):GlobalData
◆発行日:2016年2月25日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

PDI, lnc. (PDI) is a healthcare commercialization company that offers insight-driven, integrated multi-channel message delivery for healthcare companies in the US. The company provides services which include outsourced sales and marketing, digital and multi-channel promotional solutions, optimization of clients’ commercial investments, product commercialization services, personal selling, strategic planning and management, managed market support, supply chain management and regulatory and legal management, among others. It offers solutions for reaching and engaging customers; manage their portfolios; and commercialize products. The company serves pharmaceutical, biotech, medical device, and diagnostics companies. PDI is headquartered in Parsippany, New Jersey, the US.

PDI, lnc. (PDII) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
PDI, lnc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
PDI, lnc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
PDI, lnc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
PDI, lnc., Medical Equipment, Deals By Market, 2010 to YTD 2016 9
PDI, lnc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
PDI, lnc., Medical Equipment, Deal Details 11
Asset Purchase 11
PDI Acquires MiRInform Thyroid and Pancreas Cancer Test Assets from Asuragen 11
Acquisition 13
PDI Acquires RedPath Integrated Pathology for USD23 Million 13
PDI Receives Option To Acquire Molecular Diagnostics Company 15
PDI, lnc. – Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Dec 07, 2015: PDI Implements Broad Based Efficiencies To Position Interpace Diagnostics For Long Term Growth 19
Financial Announcements 20
Nov 12, 2015: PDI Reports 2015 Third Quarter and Nine Months Financial Results 20
Aug 13, 2015: PDI Reports 2015 Second Quarter and Six Months Financial Results 22
May 12, 2015: PDI Reports 20% First Quarter 2015 Revenue Growth 24
Mar 03, 2015: PDI Reports Fourth Quarter and Full Year 2014 Financial Results 26
Corporate Communications 28
Dec 22, 2015: PDI Implements Leadership Transition 28
Product News 29
Feb 17, 2016: Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR Micro RNA Gene Expression Classifer 29
Jan 28, 2016: PancraGen Clinical Utility Study Published in Diagnostic Pathology 30
Jan 20, 2016: Interpace Diagnostics Announces New Medicare Local Coverage Determination for Molecular Testing of Pancreatic Cysts 31
Jan 12, 2016: Interpace Diagnostics’ New Molecular Test for Thyroid Nodules Now Available Through LabCorp 32
May 14, 2015: Interpace Diagnostics Presents New Data at American Association of Clinical Endocrinologists Annual Congress Demonstrating Unsurpassed Performance of ThyraMIR in Combination with ThyGenX 33
Apr 15, 2015: PDI Subsidiary Interpace Diagnostics Sets New Precedent with Launch of ThyraMIR, First and Only MicroRNA Gene Expression Classifier for Thyroid Nodule Identification 34
Mar 09, 2015: PDI Announces New Data Supporting Use of ThyraMIR – First and Only MicroRNA Gene Expression Classifier – with ThyGenX Thyroid Oncogene Panel to Improve Identification of Both Benign and Malignant Thyroid Nodules 35
Other Significant Developments 36
Jan 12, 2016: New PDI Visual Resource Highlights How Proper Disinfection Can Reduce Central Line-associated Bloodstream Infections 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
PDI, lnc., Medical Equipment, Key Facts, 2014 1
PDI, lnc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
PDI, lnc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
PDI, lnc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
PDI, lnc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
PDI, lnc., Deals By Market, 2010 to YTD 2016 9
PDI, lnc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
PDI Acquires MiRInform Thyroid and Pancreas Cancer Test Assets from Asuragen 11
PDI Acquires RedPath Integrated Pathology for USD23 Million 13
PDI Receives Option To Acquire Molecular Diagnostics Company 15
PDI, lnc., Key Competitors 16
PDI, lnc., Key Employees 17
PDI, lnc., Subsidiaries 18

List of Figures
PDI, lnc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
PDI, lnc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
PDI, lnc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
PDI, lnc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
PDI, lnc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
PDI, lnc., Medical Equipment, Deals by Type, 2010 to YTD 2016 7
PDI, lnc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
PDI, lnc., Medical Equipment, Deals by Market, 2010 to YTD 2016 9

★海外企業調査レポート[PDI, lnc. (PDII):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Retail Properties, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' National Retail Properties, Inc …
  • iMDsoft Inc.:企業のM&A・提携動向(医療機器分野)
    Summary iMDsoft Inc. (iMDsoft) is a medical software company that designs, develops and implements clinical information systems (CIS) and electronic medical records (EMRs) for critical, perioperative and acute care environment. The company offers wide range of products for digitizes electronic obser …
  • General Dynamics Ordnance and Tactical Systems, Inc.(航空宇宙・防衛):企業概要及びSWOT分析
    Summary Strategic Defence Intelligence's "General Dynamics Ordnance and Tactical Systems, Inc.: Aerospace and Defense - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products a …
  • Li & Fung Limited:企業のM&A・提携・投資分析
    Li & Fung Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Li & Fung Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • ID Support Services Holdings, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ID Support Services Holdings, L …
  • Groupe Bruxelles Lambert SA (GBLB):企業の財務・戦略的SWOT分析
    Groupe Bruxelles Lambert SA (GBLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Wolf Verpackungsmaschinen GmbH:企業の戦略・SWOT・財務分析
    SummaryWolf Verpackungsmaschinen GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Akashi Therapeutics Inc:企業のM&A・提携動向(医療分野)
    Summary Akashi Therapeutics Inc (Akashi Therapeutics) develops treatment for duchenne muscular dystrophy (DMD) and other rare pediatric diseases. The company’s pipeline portfolio includes HT-100, a small molecule drug candidate for the reduction of fibrosis and inflammation and to promote healthy mu …
  • Jacada Ltd. (JCDAF):企業財務及び戦略的SWOT分析
    Summary Jacada Ltd. (Jacada) is a software solution provider that offers desktops and process optimization software solutions. The company offers agent empowerment and productivity products such as Jacada workspace agent desktop, Jacada agent scripting and Jacada advisor. It also provides mobile sel …
  • Syn-Tech Chem & Pharm Co Ltd (1777):企業財務及び戦略的SWOT分析
    Summary Syn-Tech Chem & Pharm Co Ltd (Syn-Tech) is a manufacturer and distributor of active pharmaceutical ingredients and other medical vaccines. The company’s products include phenylephrine HCl, amisulpride, articaine, clofibrate, cloperastine HCl, crotamiton, diclofenac diethylamine, diclofenac e …
  • Anworth Mortgage Asset Corporation (ANH):企業財務及び戦略的SWOT分析
    Summary Anworth Mortgage Asset Corporation (Anworth) is a mortgage real estate investment trust that invests primarily in mortgage-backed securities on a leveraged basis. The trust operates through port folios which include agency credit-backed securities, and non-agency credit-backed securities. It …
  • Central Garden & Pet Company:企業の戦略・SWOT・財務分析
    Central Garden & Pet Company - Strategy, SWOT and Corporate Finance Report Summary Central Garden & Pet Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Taisho Pharmaceutical Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Taisho Pharmaceutical Co., Ltd. …
  • ECE Projektmanagement G.m.b.H. and Co. KG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ECE Projektmanagement G.m.b.H. …
  • Pacific Hydro Pty Ltd.:企業のM&A・提携動向(発電分野)
    Summary Pacific Hydro Pty Ltd. (Pacific Hydro) a subsidiary of IFM Australian Infrastructure Fund is a global energy solutions provider that undertakes the development and operations of the renewable power projects. The company includes wind, hydro, solar and geothermal power projects at varying sta …
  • International Dairy Queen, Inc.:企業の戦略的SWOT分析
    International Dairy Queen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Rejlers AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rejlers AB Mergers and Acquisit …
  • BioStar Pharmaceuticals Inc (BSPM):企業財務及び戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a pharmaceutical company that develops, manufactures and markets pharmaceutical and healthcare nutrient products. The company’s product Ao Xing Oleanolic Acid Capsule, is an over-the-counter medicine used for the treatment of chronic hepatitis B. It a …
  • Martinrea International Inc.:企業の戦略・SWOT・財務分析
    SummaryMartinrea International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Greatcell Solar Ltd (GSL)-エネルギー分野:企業M&A・提携分析
    Summary Greatcell Solar Ltd (Greatcell Solar), formerly Dyesol Limited, is a renewable energy company that develops and commercializes Perovskite Solar Cells (PSC) or solid-state dye solar cell (DSC), the third generation photovoltaic technology. The company develops a range of PSC chemicals, compon …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆